Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Convertible Debt (2025 - 2026)

Updated

Lakefront Biotherapeutics' Convertible Debt was $25.26 million in the quarter ended Mar 31, 2026, down 29.8% from $35.97 million a year earlier but up 2.5% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Convertible Debt (2025 - 2026) Analysis & Trends

As of Dec 31, 2025, Convertible Debt at Lakefront Biotherapeutics came in at $23.92 million.

  • Quarterly Convertible Debt has moved between $23.03 million (the quarter ended Jun 30, 2025) and $35.97 million (the quarter ended Mar 31, 2025) over five years.
  • Per Business Quant data, LKFT's Convertible Debt in the three quarters before the quarter ended Mar 31, 2026 was $24.65 million (quarter ended Dec 31, 2025), $24.28 million (quarter ended Sep 30, 2025) and $23.03 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 24.72 Mn
Dec 31, 2025 24.87 Mn
Sep 30, 2025 24.36 Mn
Jun 30, 2025 23.86 Mn
API Access

Lakefront Biotherapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=LKFT&period=max&api_key=YOUR_API_KEY